<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-2ASAAB24</identifier><date>2007</date><creator>Sonc, Monika</creator><relation>documents/doc/2/URN_NBN_SI_doc-2ASAAB24_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-2ASAAB24_001.txt</relation><format format_type="issue">1</format><format format_type="volume">11</format><format format_type="type">article</format><format format_type="extent">str. 36</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">482939</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-2ASAAB24</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Drug effects</subject><subject language_type_id="eng">Pharmacology</subject><title>Poročilo s 35. evropskega kongresa kliničnih farmacevtov</title></Record>